Good embolization response for colorectal liver metastases with hypervascularity

Hepato-Gastroenterology

Volumn 49, Issue 48, 2002, Pages 1531-1534

  Taniai, Nobuhiko ^a   Onda, Masahiko ^a   Tajiri, Takashi ^a   Furukawa, Kiyonori ^a   Takasaki, Hideaki ^a   Yoshimura, Kazuyasu ^a   Yoshida, Hiroshi ^a   Mamada, Yasuhiro ^a   Akimaru, Koho ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Colorectal cancer; Liver metastatis; Transcatheter arterial embolization (TAE)

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ARTERIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036841639     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fong Y, Salo J: Surgical therapy of hepatic colorectal metastasis. Sem Oncol 1999; 26:514-523.
2. Scheele J, Altendorf-Hofmann AS: Resection of colorectal liver metastases. Langenbecks Arch Surg 1999; 384:313-327.
3. Harmon KE, Ryan JA Jr, Biehl TR, et al: Benefits and safety of hepatic resection for colorectal metastases. Am J surg 1999; 177:402-404.
4. Bradley AL, Chapman WC, Wright JK, et al: Surgical experiences with hepatic colorectal metastasis. Am Surg 1999; 65:560-5666.
5. Nakamura S, Suzuki S, Konno H: Resection of hepatic metastases of colorectal carcinoma; 20 years' experience. J Hepatobiliary Pancreat Surg 1999; 6:16-22.
6. Rose DM, Chapman WC, Brockenbrough AT, et al: Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 1999; 177:405-410.
7. Lic CL, Fan ST: Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 73:358-365.
8. Trinchet JC, Beaugarand M: Treatment for hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1997; 27:756-765.
9. Venook AP: Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 1994; 12:1323-1334.
10. Leichman CG, Jacobson JR, Modiano M, et al: Hepatic chemoembolization combined with systemic infusion of 5-Fluorouracil and bolus Leucovorin for patients with metastatic colorectal carcinoma. Cancer 1999; 86:775-781.
11. Hunt TM, Flowerdew ADS, Birch SJ, et al: Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starches microspheres for colorectal liver metastases. Br J Surg 1990; 77:779-782.
12. Healy JE, Sheena KS: Vascular patterns in metastatic liver tumor. Surg Forum 1963; 2:121-122.
13. Collins JM: Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2:498-504.
14. Konno T, Kai Y, Yamashita R, et al: Targeted chemotherapy for undetectable primary and metastatic liver cancer. Acta Oncol 1994; 33:133-137.
15. Lang E, Brown CL: Colorectal metastases to the liver: selective chemoembolization. Radiology 1993; 189:417-422.
16. Sanz-Altamira PM, Spence LD, Huberman MS, et al: Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma. Dis Colon Rectum 1997; 40:770-775.
17. Kameyama M, Imaoka S, Fukuda I, et al: Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer. Surgery 1993; 114:97-101.